KGLCX
Price
$15.58
Change
-$0.36 (-2.26%)
Updated
Nov 13 closing price
Net Assets
61.18M
RLBBX
Price
$38.70
Change
-$0.49 (-1.25%)
Updated
Nov 13 closing price
Net Assets
268.67B
Interact to see
Advertisement

KGLCX vs RLBBX

Header iconKGLCX vs RLBBX Comparison
Open Charts KGLCX vs RLBBXBanner chart's image
Kinetics Global Adv C
Price$15.58
Change-$0.36 (-2.26%)
VolumeN/A
Net Assets61.18M
American Funds American Balanced R2
Price$38.70
Change-$0.49 (-1.25%)
VolumeN/A
Net Assets268.67B
KGLCX vs RLBBX Comparison Chart in %
View a ticker or compare two or three
VS
KGLCX vs. RLBBX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KGLCX is a Buy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 269B vs. KGLCX (61.2M). RLBBX pays higher dividends than KGLCX: RLBBX (1.09) vs KGLCX (0.34). KGLCX was incepted earlier than RLBBX: KGLCX (18 years) vs RLBBX (24 years). KGLCX (2.79) is less costly to investors than RLBBX (1.32). RLBBX is a more actively managed with annual turnover of: 44.00 vs. KGLCX (34.00). RLBBX has a lower initial minimum investment than KGLCX: RLBBX (250) vs KGLCX (2500). RLBBX annual gain was more profitable for investors over the last year : 9.11 vs. KGLCX (4.15). KGLCX return over 5 years is better than : 156.88 vs. RLBBX (36.96).
KGLCXRLBBXKGLCX / RLBBX
Total Expense Ratio2.141.32162%
Annual Report Gross Expense Ratio2.791.32211%
Fund Existence18 years24 years-
Gain YTD8.80515.50057%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets61.2M269B0%
Annual Yield % from dividends0.341.0931%
Returns for 1 year4.159.1146%
Returns for 3 years96.9840.59239%
Returns for 5 years156.8836.96424%
Returns for 10 years263.5870.07376%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALPMY11.990.35
+3.01%
Astellas Pharma, Inc.
AHICF16.28N/A
N/A
Asahi Intec Co., Ltd.
PGNN12.00N/A
N/A
Paragon Financial Solutions, Inc. (TN)
QKIE1.20N/A
N/A
QKI Emulsion Inc.
ORLCF0.03N/A
-11.57%
ORACLE COMMODITY HLDG CORP